More FDA Meetings Postponed, Canceled due to Coronavirus

Following an announcement last week that the US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) would be cancelling, postponing or virtually hosting its upcoming meetings in light of the coronavirus disease (COVID-19) outbreak, the agency now says it will do so for “all non-essential meetings” through April.